Identification of a novel DNA repair-related prognostic signature predicting survival of patients with hepatocellular carcinoma
Cancer Management and Research Aug 09, 2019
Li N, et al. - Researchers used The Cancer Genome Atlas, gene set enrichment analysis, and Cox proportional hazards regression model to develop a novel DNA repair-related gene signature that combines various genes to improve prognosis prediction in hepatocellular carcinoma (HCC). They constructed a gene signature using a set of seven genes, namely, ADA, FEN1, POLR2G, SAC3D1, SEC61A1, SF3A3, and UPF3B, which showed a significant relation to overall survival. They calculated the signature risk score, which was used to classify patients into high- and low-risk groups. The worse prognosis was seen in the high-risk group. In univariate and multivariate Cox regression analysis, this risk score signature displayed a robust prognostic performance in various subgroups based on clinicopathological characteristics, with P-values < 0.05, suggesting that it can be used as an independent prognostic indicator. Overall, a seven-gene signature associated with the DNA repair process was constructed and identified, which could predict survival in HCC. Findings revealed its efficacy for classification and for guiding clinical treatment.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries